Cofactors of partner HIV self-testing and Oral PrEP acceptance among pregnant women at high risk of HIV in Kenya

Abstract

Background: Oral PrEP and male partner HIV self-testing (HIVST) is being scaled up within antenatal clinics (ANC). Few data are available on how co-distribution influences acceptance of both interventions. Methods: We utilized data from the PrIMA (NCT03070600) trial in Kenya. Women included in this analysis were determined to be at high risk of HIV and offered oral PrEP and partner HIVST. Characteristics were compared between women who chose: 1) PrEP and HIVST, 2) HIVST-alone, 3) PrEP-alone, or 4) declined both (reference), excluding women who had partners known to be living with HIV. Results: Among 911 women, median age was 24 years, 87.3% were married, 43.9% perceived themselves to be at high risk of HIV and 13.0% had history of intimate partner violence (IPV). Overall, 68.9% accepted HIVST and 18.4% accepted PrEP with 54.7% accepting HIVST-alone, 4.2% PrEP-alone and 14.3% both HIVST and PrEP. Of women accepting HIVST, partner HIV testing increased from 20% to 82% and awareness of partner HIV status increased from 4.7% to 82.0% between pregnancy and 9-months postpartum (p<0.001). Compared to women who accepted neither, choosing: 1) HIVST-alone was associated with being married, higher level of education, and residing with partner; 2) PrEP-alone with lower social support, IPV, not residing with partner, longer time living with partner, and suspicion of other partners; and 3) PrEP and HIVST was associated with being married, IPV, and suspicion that partner had other partners. Conclusion: Understanding factors associated with accepting HIVST and PrEP can inform HIV prevention programs for pregnant women. Clinical Trial Number: NCT03070600